LabPulse.com staff writers

Financing
Harbinger Health raises $140M in series B funding
Biotech company Harbinger Health has raised $140 million in a series B funding round.
September 29, 2023
Artificial Intelligence Drug Design Funding Social
Agreement
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
September 29, 2023
Test Tube Liquid Sample Social
Kickback
U.S. Attorney’s Office wins $370M judgment in Medicare fraud case
The U.S. Attorney's Office for the Middle District of Florida won a $370 million default judgment against a Kentucky lab owner and his businesses for a lab testing scheme intended to defraud Medicare.
September 28, 2023
Gavel Money Social
Collaboration
Ginkgo Bioworks, Pfizer collaborate on RNA-based therapeutics
Cell engineering company Ginkgo Bioworks has entered into an agreement with Pfizer to discover and develop RNA-based drug candidates.
September 28, 2023
Rna Strand Social
COVID-19
Study launched on early intervention with immune modulators in COVID-19
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
COVID-19
U.S. government investing $600M in COVID-19 test manufacturing
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Dollar Money Coronavirus Mask Social
Stock
Invitae receives noncompliance notice from NYSE
San Francisco-based medical genetics company Invitae received a notice of noncompliance from the New York Stock Exchange (NYSE) on September 20 for its stock price closing under $1.00 per share for 30 consecutive days.
September 25, 2023
Business Graph Money Stocks Social
HIV
HIV vaccine trial begins enrollment in U.S., South Africa
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
Artificial Intelligence
AI model reveals kidney tumor features, potential for treatment response prediction
Researchers at the Dana-Farber Cancer Institute have trained artificial intelligence (AI) models to assess the clinical features of kidney cancer tumor samples to predict how tumors may respond to immune therapy.
September 22, 2023
Kidney Social
Regulatory Guidance
NIH to require international collaborators to share all data
Despite concerns from researchers and organizations, the U.S. National Institutes of Health (NIH) will implement its new mandate requiring foreign partners to share raw data and notebooks at regular set intervals with their primary U.S. grant recipients.
September 22, 2023
Lab Scientists Social
Page 1 of 321
Next Page
Top Stories
Test Tube Liquid Sample Social
Agreement
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
Cigarette Smoking Social
Schizophrenia
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
Artificial Intelligence Drug Design Funding Social
Financing
Harbinger Health raises $140M in series B funding
Plasmodium Falciparum Malaria Cdc Social
Malaria
Study shows malaria drug resistance occurring in Horn of Africa
Latest in at-home or lab-based STI testing
Sponsor Content
Latest in at-home or lab-based STI testing
More in Home
BioMérieux subsidiary secures DoD contract for infectious disease testing system
BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.
September 29, 2023
Test Tube Liquid Sample Social
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
Genetic factors are unlikely to directly drive the increased rate of cardiovascular disease in schizophrenia patients but may influence lifestyle, according to a paper in the American Journal of Psychiatry.
September 29, 2023
Cigarette Smoking Social
Harbinger Health raises $140M in series B funding
Biotech company Harbinger Health has raised $140 million in a series B funding round.
September 29, 2023
Artificial Intelligence Drug Design Funding Social
Study shows malaria drug resistance occurring in Horn of Africa
Malaria parasites in eastern Africa have developed resistance to artemisinins, essential first-line drugs used in combination therapies, jeopardizing the progress made in recent decades against the disease.
September 29, 2023
Plasmodium Falciparum Malaria Cdc Social
Day Zero Diagnostics to use $16M in funding to improve management of antibiotic-resistant infections
Day Zero Diagnostics recently raised $16 million to fund the application of whole-genome sequencing and artificial intelligence to antibiotic-resistant infections, facilitating the firm’s goal of changing how infectious diseases are diagnosed.
September 28, 2023
Dna Sequencing2
U.S. Attorney’s Office wins $370M judgment in Medicare fraud case
The U.S. Attorney's Office for the Middle District of Florida won a $370 million default judgment against a Kentucky lab owner and his businesses for a lab testing scheme intended to defraud Medicare.
September 28, 2023
Gavel Money Social
Ginkgo Bioworks, Pfizer collaborate on RNA-based therapeutics
Cell engineering company Ginkgo Bioworks has entered into an agreement with Pfizer to discover and develop RNA-based drug candidates.
September 28, 2023
Rna Strand Social
Study launched on early intervention with immune modulators in COVID-19
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
U.S. government investing $600M in COVID-19 test manufacturing
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Dollar Money Coronavirus Mask Social
Some emergency sepsis screening tools inadequate, EU study suggests
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Sepsis Bacteria Social
Thermo Fisher Scientific prepared to expand its work at manufacturing facility
Thermo Fisher Scientific executives voiced hopes for expanding work to help combat diseases at its giant $180 million viral vector manufacturing site in Plainville, MA.
September 27, 2023
Manufacturing Facility Process Social
HIV vaccine trial begins enrollment in U.S., South Africa
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
Page 1 of 92
Next Page